Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Outros
|
[89Zr]Zr-Girentuximab PET/CT for the targeted diagnosis of clear cell renal cell carcinoma (ccRCC)Painting, A ; Vyas, Madhusudan ; Fagan, J ; Lim, RAustralian and New Zealand Society of Nuclear Medicine 2023Texto completo disponível |
|
2 |
Material Type: Outros
|
A first NZ study looked at the role of Lutetium-177-PSMA I & T in the progression of mCRPCVyas, Madhusudan2022Texto completo disponível |
|
3 |
Material Type: Outros
|
A first New Zealand study looked at the role of lutetium-177-P SMA I &T in the progression of metastatic castrate-resistant prostate cancerVyas, Madhusudan ; Garett, N ; Lim, R ; Fagan, J2021Texto completo disponível |
|
4 |
Material Type: Outros
|
Lutetium-177-PSMA I&T for progressing metastatic castrate-resistant prostate cancer : a single NZ centre experienceVyas, Madhusudan ; Fagan, J ; Lim, R ; Garett, N2020Texto completo disponível |
|
5 |
Material Type: Outros
|
Nuclear reactor to the hot lab : an overview of the radiochemistry of Lu-177Vyas, Madhusudan2019Texto completo disponível |
|
6 |
Material Type: Outros
|
A ray of hope patients with metastatic castration-resistant prostate cancer (mCRPC) sufferers : positive impacts of the Lu177- PSMA treatment in the advanced stage of prostate cancerVyas, Madhusudan ; Fagan, Jessica ; Shaikh, Shamim2019Texto completo disponível |
|
7 |
Material Type: Outros
|
|
|
8 |
Material Type: Outros
|
Comparison of adverse event reporting between adolescent and young adults and older adults with cancer enrolled in Phase II/III clinical trialsWayant, Cole ; Fitzgerald, Kyle ; Hemmerich, Christian ; Roth, MichaelOklahoma State University Center for Health Sciences 2023Texto completo disponível |
|
9 |
Material Type: Outros
|
How to see the invisible cancer? 18-FDG, PET/CT case studiesPenchev, Boris ; Chaushev, B ; Pencheva, Lora B2015Texto completo disponível |
|
10 |
Material Type: Outros
|
|